BNP Paribas Financial Markets
CLOV icon

BNP Paribas Financial Markets’s Clover Health Investments CLOV Stock Holding History

BNP Paribas Financial Markets’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Sell
90,337
-53
-0.1% -$115 ﹤0.01% 4151
2025
Q4 		$212K Buy
90,390
+11,855
+15% +$32.4K ﹤0.01% 4031
2025
Q3 		$240K Buy
78,535
+43,884
+127% +$125K ﹤0.01% 3922
2025
Q2 		$96.7K Sell
34,651
-5,586
-14% -$18.4K ﹤0.01% 4029
2025
Q1 		$144K Sell
40,237
-251,499
-86% -$1.01M ﹤0.01% 3888
2024
Q4 		$919K Buy
+291,736
New +$1.04M ﹤0.01% 2884

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's CLOV Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Clover Health Investments (CLOV) stake by 0.06% in Q1 2026, selling an estimated $115 and leaving 90,337 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #4151.

BNP Paribas Financial Markets first reported a position in CLOV in Q4 2024 and has held it in 6 quarters since. The position peaked at $919K in Q4 2024. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • BNP Paribas Financial Markets held 90,337 shares of Clover Health Investments worth $159K as of Q1 2026.
  • BNP Paribas Financial Markets sold 53 Clover Health Investments shares in Q1 2026, an estimated $115.
  • Clover Health Investments made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4151 holding.
  • BNP Paribas Financial Markets first reported a position in Clover Health Investments in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Clover Health Investments position peaked at $919K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.